Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Neeraj Gupta

36PUBLICATIONS
62CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursPharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

Sort by Publication Date:
|Nov 17, 2025
A Phase 1 Study to Assess the Effect of Fruquintinib on the Pharmacokinetics of P-gp and BCRP Substrates in Healthy Subjects.

Martha Gonzalez, Zhao Yang, William R Schelman

|Jul 21, 2025
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling of Serum M-Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma.

Cheryl Li, Andrew Santulli, Scott Van Wart

|Mar 17, 2025
Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure-Response Analysis.

Xiaofei Zhou, Diane R Mould, Lia Gore

|Mar 13, 2025
Assessment of Food Effect and pH-Dependent Drug-Drug Interactions of Fruquintinib in Healthy Subjects.

Martha Gonzalez, Zhao Yang, William R Schelman

|Mar 03, 2025
Population Pharmacokinetic and Exposure-Response Analyses for Ponatinib in the Phase 3 PhALLCON Study.

Michael J Hanley, Thomas R Larson, Paul M Diderichsen

|Sep 17, 2024
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone.

Yuki Otani, Yunqi Zhao, Guanyu Wang

Pageof 6

Frequent Collaborators

13 joint publications

Karthik Venkatakrishnan

13 joint publications

Michael J Hanley

4 joint publications

Paul M Diderichsen

3 joint publications

Xiaofei Zhou

2 joint publications

Shaji Kumar

2 joint publications

Tomoko Yanai

2 joint publications

Chia-Chi Lin

2 joint publications

Kan Yonemori

2 joint publications

Toshio Shimizu

2 joint publications

Meera Tugnait

Frequent Collaborators

13 joint publications

Karthik Venkatakrishnan

13 joint publications

Michael J Hanley

4 joint publications

Paul M Diderichsen

3 joint publications

Xiaofei Zhou

Top Related Videos

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [<sup>11</sup>C]SNAP-7941
09:50

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [<sup>11</sup>C]SNAP-7941

Published on : Apr 28, 2019

7.9K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on : Jul 15, 2015

8.7K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on : Jan 29, 2019

10.1K
See more related videos

Top Related Videos

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [<sup>11</sup>C]SNAP-7941
09:50

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [<sup>11</sup>C]SNAP-7941

Published on : Apr 28, 2019

7.9K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on : Jul 15, 2015

8.7K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on : Jan 29, 2019

10.1K
See more related videos